Hussman Strategic Advisors’s Globus Medical GMED Stock Holding History

Hussman Strategic Advisors’s Portfolio GMED Stock Details GMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.32M	Buy	+42,000	New	+$3.57M	0.76%	28
2025 Q2	–	Sell	-52,500	Closed	-$3.84M	–	246
2025 Q1	$3.84M	Buy	+52,500	New	+$4.34M	0.93%	15
2018 Q1	–	Sell	-50,000	Closed	-$2.06M	–	227
2017 Q4	$2.06M	Hold	50,000	–	–	0.59%	85
2017 Q3	$1.49M	Buy	+50,000	New	+$1.53M	0.36%	109
2016 Q2	–	Sell	-200,000	Closed	-$4.75M	–	189
2016 Q1	$4.75M	Buy	+200,000	New	+$4.89M	0.63%	62

Other funds holding GMED

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Sculptor Capital New York $12.3B AUM 40.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Hussman Strategic Advisors's GMED Position: Q2 2026 in Review

Hussman Strategic Advisors opened a new position in Globus Medical (GMED) in Q2 2026: 42,000 shares worth $3.32M. The stake represents 0.76% of the portfolio and ranks #28 among its holdings. This is a return to the name: Hussman Strategic Advisors previously reported a position in GMED as recently as Q1 2025.

Hussman Strategic Advisors first reported a position in GMED in Q1 2016 and has held it in 5 quarters since. The position peaked at $4.75M in Q1 2016. 599 funds tracked by Wall St. Rank hold GMED as of Q2 2026.

Hussman Strategic Advisors held 42,000 shares of Globus Medical worth $3.32M as of Q2 2026.
Globus Medical was a new Hussman Strategic Advisors position in Q2 2026.
Globus Medical made up 0.76% of Hussman Strategic Advisors's portfolio in Q2 2026, its #28 holding.
Hussman Strategic Advisors first reported a position in Globus Medical in Q1 2016 and has held it in 5 quarters since.
Hussman Strategic Advisors's Globus Medical position peaked at $4.75M in Q1 2016.
599 funds tracked by Wall St. Rank held Globus Medical as of Q2 2026.

Based on Hussman Strategic Advisors's 13F filing for Q2 2026, filed 3 Aug 2026.